Update from large animal pilot dosing study of BB-301 for oculopharyngeal muscular dystrophy Sep. 9, 2021
ProQR and Lilly to use Axiomer RNA editing platform to target liver and nervous system disorders Sep. 9, 2021
Synthesis and optimization of LRRK2 inhibitors using a CHK1-derived crystallographic surrogate Sep. 9, 2021
Algernon's in vitro study shows DMT increases growth of neurons at subhallucinogenic dose Sep. 8, 2021
RSS